IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $9,000 | -93.6% | 656 | -89.0% | 0.00% | -100.0% |
| Q3 2016 | $141,000 | +370.0% | 5,938 | +477.1% | 0.00% | – |
| Q2 2016 | $30,000 | -79.5% | 1,029 | -77.4% | 0.00% | -100.0% |
| Q1 2016 | $146,000 | -77.6% | 4,549 | -70.2% | 0.00% | -83.3% |
| Q4 2015 | $652,000 | -45.1% | 15,241 | -54.8% | 0.01% | -50.0% |
| Q3 2015 | $1,187,000 | -57.9% | 33,716 | -45.1% | 0.02% | -33.3% |
| Q2 2015 | $2,820,000 | +56.3% | 61,422 | +59.6% | 0.04% | +56.5% |
| Q1 2015 | $1,804,000 | -29.4% | 38,488 | -52.3% | 0.02% | -23.3% |
| Q4 2014 | $2,556,000 | +96.8% | 80,667 | +47.2% | 0.03% | -33.3% |
| Q3 2014 | $1,299,000 | -26.8% | 54,788 | -7.4% | 0.04% | +125.0% |
| Q2 2014 | $1,775,000 | – | 59,192 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |